Pristimerin synergistically sensitizes conditionally reprogrammed patient derived-primary hepatocellular carcinoma cells to sorafenib through endoplasmic reticulum stress and ROS generation by modulating Akt/FoxO1/p27kip1 signaling pathway
Yubo Tang, Jie Chen, Jiaqi Li, Yifan Zheng, Xiuxiu Zhong, Shuai Huang, Bin Chen, Baogang Peng, Xuenong Zou, Xiao Chen
Topics & Concepts
ApoptosisCancer researchSorafenibHepatocellular carcinomaEndoplasmic reticulumAngiogenesisChemistryUnfolded protein responseBiologyPharmacologyCell biologyBiochemistryNatural Compounds in Disease TreatmentHistone Deacetylase Inhibitors ResearchBerberine and alkaloids research